Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
25/07/2023 21:52
July 25 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMACEUTICALS - ON JULY 24 APPROVED PLAN TO
REDUCE
CO'S OVERALL HEADCOUNT BY 21 POSITIONS, REPRESENTING ABOUT 78%
OF COMPANY'S WORKFORCE
* INFINITY PHARMACEUTICALS INC - WORKFORCE REDUCTION IS
EXPECTED
TO BE COMPLETED BY END OF Q3 OF 2023
* INFINITY PHARMACEUTICALS - EXPECTS TO INCUR ONE-TIME
CHARGE IN
Q3 OF 2023 OF ABOUT $3.4 MILLION FOR WORKFORCE REDUCTION
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX